Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Rating) has been given an average recommendation of “Buy” by the six research firms that are currently covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a buy rating. The average 12-month price target among brokers that have covered the stock in the last year is […]
Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Rating) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $12.76 and last traded at $13.10, with a volume of 16849 shares trading hands. The stock had previously closed at $13.56. Wall Street Analyst Weigh In MLYS has been […]
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Rating) shares were down 2.8% during mid-day trading on Tuesday . The stock traded as low as $14.18 and last traded at $14.26. Approximately 13,794 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 247,107 shares. The stock had previously closed at […]